drugset / Trial / NCT02627248

Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

NCT02627248

Phase 4 Unknown 200 enrolled Shandong University
RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Huaier (Trametes robiniophila Murr) is a traditional Chinese medicine, which has been widely used in China for many years. The investigators have found that Huaier could exert synergistic effects with Epirubicin, Cyclophosphamide, and Paclitaxel on breast cancer cells. It is not yet known whether combination chemotherapy is more effective when given together with Huaier in the neoadjuvant setting . PURPOSE: To evaluate the effects of treatment with Huaier Granule in managing locally advanced breast cancers with synergistic action of the neoadjuvant chemotherapy.

Timeline

Start
2015-10
Primary completion
2025-10
Completion
2025-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 600 mg/m2 Intravenous
Subject Huaier Granule Traditional medicine (herbal / TCM) 20 g Oral
Background Docetaxel Small molecule 75 mg/m2 Intravenous
Background Epirubicin Small molecule 70 mg/m2 Intravenous

Indications